May 18 | News
Xavant Technology, a medical device company specializing in
the development and manufacturing of nerve stimulators, has launched a
breakthrough nerve stimulator, the Stimpod NMS450.
|
May 15 | News
Bioness Inc. today announced it has received 510(k)
clearance from the U.S. Food and Drug Administration (FDA) to market a smaller
leg cuff for use with the company’s L300® Foot Drop System. The L300 is a
neuromodulation technology designed to treat foot drop...
|
May 2 | News
London’s Air Ambulance, the
Charity which runs London’s Helicopter Emergency
Medical Service, has become the first in the UK to trial a novel device for
directly cooling the brain using evaporative, nasal spray technology, the
RhinoChill® IntraNasal Cooling System...
|
Apr 13 | News
CAMBRIDGE,
Mass.--(BUSINESS WIRE)--InVivo Therapeutics
Holdings Corp., a developer of groundbreaking technologies for the treatment of
spinal cord injuries (SCI), announced today that it held a meeting with the
U.S. Food and Drug Administration (“FDA”) in which...
|
Apr 5 | Videos
Epilepsy affects 50 million people worldwide, but in a third of these cases, medication cannot keep seizures from occurring. One solution is to shoot a short pulse of electricity to the brain to stamp out the seizure just as it begins to erupt. But brain implants designed to do this have...
|
Feb 9 | News
WASHINGTON--(BUSINESS
WIRE)--By harnessing quantum dots—tiny light-emitting semiconductor
particles a few billionths of a meter across—researchers at the University of Washington
(UW) have developed a new and vastly more targeted way to stimulate neurons in
the brain.
|
Feb 8 | News
WILMINGTON, Mass.--(BUSINESS WIRE)--Sensable’s
customers will feature prominently at the Medicine
Meets Virtual Reality (MMVR) Conference in Newport Beach, California
beginning tomorrow, where they will showcase innovative haptically-enabled
surgical, medical simulation...
|
Feb 3 | News
ATLANTA--(BUSINESS WIRE)--In 2011, the National
Institute of Health spent more than $6 billion on cancer research, compared to
less than $480 million on Alzheimer’s disease research. Those numbers do not
seem alarming until you learn there are over 5.4 million people in the United
States...
|
Jan 24 | News
VAL D’ISERE, France--(BUSINESS
WIRE)--At last week’s ABC-WIN Seminar, Prof. Dr. Michael Knauth, Director
of Neuroradiology, University Hospital of Goettingen, Goettingen, Germany, and
President-elect of the German Society of Neuroradiology, presented the European
evaluation...
|
Jan 24 | News
SAN LUIS OBISPO, Calif.--(BUSINESS WIRE)--FzioMed, Inc. is
pleased to announce that it has received CE Mark approval to market DYNAVISC®
adhesion barrier gel in Europe for tendon and peripheral nerve surgery.
DYNAVISC is a clear, absorbable gel supplied ready-to-use...
|
Jan 19 | News
ANN ARBOR,
Mich.--(BUSINESS WIRE)--Biotectix, LLC, an
Allied Minds, Inc. subsidiary, is pleased to announce the first-in-human (FIH)
use of an electrostimulation device incorporating its BT DOT conductive polymer
coating technology. Last month, patients were surgically implanted...
|
Jan 18 | News
CAMBRIDGE, Mass. & DANVILLE, Pa.--(BUSINESS WIRE)--InVivo Therapeutics
Holdings Corp., a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), and Geisinger Health System today announced a research
collaboration to conduct a preclinical study...
|
Jan 12 | News
WAUKESHA, Wis.--(BUSINESS
WIRE)--GE Healthcare announced today a long-term agreement with Biosense
Webster, Inc., in which the companies will co-distribute their leading
electrophysiology (EP) systems — including GE’s CardioLab* EP Recording Systems
and Biosense Webster’s...
|
Jan 11 | News
GAINESVILLE, Fla. — Researchers from the University of
Florida and 14 additional medical centers reported results today in the online
version of The Lancet Neurology journal indicating that deep brain stimulation
— also known as DBS — is effective at improving motor symptoms...
|
Jan 4 | Articles
In recent years, there has been great excitement about the
use of neuromodulation to treat a wide array of medical conditions and
diseases. The technology uses electrical signals to stimulate or block
different nerve impulses in the body and is adapted from technology used in
cardiac rhythm management. Advanced ceramic materials are playing an important role in
the technology and are poised to play an even greater one as these medical
devices flood onto the market to treat an increasing number of ailments.
|
Dec 12 2011 | News
MINNEAPOLIS--(BUSINESS WIRE)--Clinical trial data presented at the 15th Annual Meeting of the North American Neuromodulation Society demonstrate the AdaptiveStim™ with RestoreSensor™ neurostimulation system from Medtronic provides clinical benefits for many patients...
|
Dec 9 2011 | News
LAS VEGAS--(BUSINESS WIRE)--Spinal Modulation, a privately held global medical device company, announced today that the Spinal Modulation Neurostimulator System has received the CE Mark for the management of chronic intractable pain. The Spinal Modulation System utilizes low-level electrical signals...
|